Fig. 5.
Survival.
DFS and OS of S, I, and R patients (A,B), R+I patients versus S patients (C,D); and S+I patients (correspond to negative patients with Rh123 assay) versus R patients (correspond to positive patients with Rh123 assay) (E,F).
Survival.
DFS and OS of S, I, and R patients (A,B), R+I patients versus S patients (C,D); and S+I patients (correspond to negative patients with Rh123 assay) versus R patients (correspond to positive patients with Rh123 assay) (E,F).
